What is CRISPR Therapeutics's capex?

CRISPR Therapeutics (CRSP) reported capex of $504K in Q1 2026.

How has CRISPR Therapeutics's capex changed year-over-year?

CRISPR Therapeutics's capex increased by 144.7% year-over-year, from $206K to $504K.

What is the long-term trend for CRISPR Therapeutics's capex?

Over 4 years (2021 to 2025), CRISPR Therapeutics's capex has grown at a -67.5% compound annual growth rate (CAGR), from $81.71M to $914K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

CRISPR Therapeutics CRSP CapEx

CapEx at other companies

Beam TherapeuticsBEAM

$2.23M-27.2%

Cogent Biosciences, Inc.COGT

$449K-17.9%

CelcuityCELC

$249K+315%

Arrowhead ResearchARWR

$2.57M-51.6%

Krystal Biotech, Inc.KRYS

$7.15M+15.2%

BridgeBio PharmaBBIO

$69K—

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's capex?: CRISPR Therapeutics (CRSP) reported capex of $504K in Q1 2026.
How has CRISPR Therapeutics's capex changed year-over-year?: CRISPR Therapeutics's capex increased by 144.7% year-over-year, from $206K to $504K.
What is the long-term trend for CRISPR Therapeutics's capex?: Over 4 years (2021 to 2025), CRISPR Therapeutics's capex has grown at a -67.5% compound annual growth rate (CAGR), from $81.71M to $914K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.